foxo4-dri senolytic mice baar 2017

foxo4-dri senolytic mice baar 2017 regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI improves spermatogenesis in aged

Name: foxo4-dri senolytic mice baar 2017 regulates endothelial cell senescence via the P53 signaling pathway FOXO4-DRI improves spermatogenesis in aged
Brand: centoria.fr
SKU: 62742021341
Price: 21.34 USD
Availability: InStock
Rating: 4.7056 (30 reviews)

FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect FOXO4 DRI Averix Labs The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine

SKU: 62742021341 · From centoria.fr

4.7

USD21.34 USD71.34

Pay in 4 interest-free payments of $5.33 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 4 - Aug 9

Description

Stability : Once reconstituted, peptides last 28 days

Molecular cell , 22 (3), 375382

Full ingredients (INCI): Water, Glycerin, Copper Tripeptide-1, Phenoxyethanol, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7 What to Expect From Our Copper Peptide Face Serum Weeks 1-2 Skin feels smoother with improved texture and comfort Weeks 3-4 Visible improvements in skin tone evenness and firmer appearance Weeks 6-8 Notable reduction in fine lines with improved elasticity Weeks 8-12 Skin texture continues improving, fine lines less prominent Weeks 12+ Ongoing support for firmer, smoother skin with daily use Individual results may vary